메뉴 건너뛰기




Volumn 30, Issue 1, 2011, Pages 57-61

The Role of Targeted Molecular Inhibitors in the Management of Advanced Nonmelanoma Skin Cancer

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO N [4 CHLORO 3 (2 PYRIDINYL)PHENYL] 4 METHANESULFONYLBENZAMIDE; ANTINEOPLASTIC AGENT; BEVACICUMAB; BEVACIZUMAB; CETUXIMAB; CISPLATIN; CITUXIMAB; FLUOROURACIL; GENMAB; GLEEVAC; IMATINIB; PANITUMUMAB; PEMETREXED; SORAFENIB; SUNITINIB; UNCLASSIFIED DRUG; ZALUTUMUMAB;

EID: 79955378067     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2011.01.004     Document Type: Review
Times cited : (13)

References (32)
  • 1
    • 0347320540 scopus 로고    scopus 로고
    • Actinic keratosis: Epidemiology and progression to squamous cell carcinoma
    • Lebwohl M. Actinic keratosis: Epidemiology and progression to squamous cell carcinoma. Br J Dermatol 2003, 149(suppl 66):31-33.
    • (2003) Br J Dermatol , vol.149 , Issue.SUPPL. 66 , pp. 31-33
    • Lebwohl, M.1
  • 2
    • 61449104877 scopus 로고    scopus 로고
    • Targeted therapies in squamous cell carcinoma of the head and neck
    • Gold K.A., Lee H.Y., Kim E.S. Targeted therapies in squamous cell carcinoma of the head and neck. Cancer 2009, 115:922-935.
    • (2009) Cancer , vol.115 , pp. 922-935
    • Gold, K.A.1    Lee, H.Y.2    Kim, E.S.3
  • 3
    • 17444410011 scopus 로고    scopus 로고
    • Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin
    • Maubec E., Duvillard P., Velasco V., et al. Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin. Anticancer Res 2005, 25:1205-1210.
    • (2005) Anticancer Res , vol.25 , pp. 1205-1210
    • Maubec, E.1    Duvillard, P.2    Velasco, V.3
  • 4
    • 38849091450 scopus 로고    scopus 로고
    • Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma
    • Ching S., Low I., Ng D., et al. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma. Human Pathol 2008, 39:344-349.
    • (2008) Human Pathol , vol.39 , pp. 344-349
    • Ching, S.1    Low, I.2    Ng, D.3
  • 5
    • 0033874137 scopus 로고    scopus 로고
    • Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas
    • Detmar M., Velasco P., Richard L., et al. Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas. Am J Pathol 2000, 156:159-167.
    • (2000) Am J Pathol , vol.156 , pp. 159-167
    • Detmar, M.1    Velasco, P.2    Richard, L.3
  • 6
    • 77954447845 scopus 로고    scopus 로고
    • Novel therapeutic approaches to squamous cell carcinoma of the head and neck using biologically targeted agents
    • Harrington K.J., Kazi R., Bhide S.A., et al. Novel therapeutic approaches to squamous cell carcinoma of the head and neck using biologically targeted agents. Indian J Cancer 2010, 47:248-259.
    • (2010) Indian J Cancer , vol.47 , pp. 248-259
    • Harrington, K.J.1    Kazi, R.2    Bhide, S.A.3
  • 7
    • 77952842632 scopus 로고    scopus 로고
    • EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma
    • Sundvall M., Karrila A., Nordberg J., et al. EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma. Expert Opin Emerg Drugs 2010, 15:185-201.
    • (2010) Expert Opin Emerg Drugs , vol.15 , pp. 185-201
    • Sundvall, M.1    Karrila, A.2    Nordberg, J.3
  • 8
    • 77953392968 scopus 로고    scopus 로고
    • Molecular targeted therapies in head and neck cancer-An update of recent developments
    • Goerner M., Seiwert T.Y., Sudhoff H. Molecular targeted therapies in head and neck cancer-An update of recent developments. Head Neck Oncol 2010, 2:8.
    • (2010) Head Neck Oncol , vol.2 , pp. 8
    • Goerner, M.1    Seiwert, T.Y.2    Sudhoff, H.3
  • 9
    • 32144433159 scopus 로고    scopus 로고
    • Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
    • Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006, 354:567-578.
    • (2006) N Engl J Med , vol.354 , pp. 567-578
    • Bonner, J.A.1    Harari, P.M.2    Giralt, J.3
  • 10
    • 51649085865 scopus 로고    scopus 로고
    • Platinum-based chemotherapy plus cetuximab in head and neck cancer
    • Vermorken J.B., Mesia R., Rivera F., et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 2008, 359:1116-1127.
    • (2008) N Engl J Med , vol.359 , pp. 1116-1127
    • Vermorken, J.B.1    Mesia, R.2    Rivera, F.3
  • 11
    • 79955449561 scopus 로고    scopus 로고
    • Genmab, Accessed January 31, 2011
    • Genmab, Accessed January 31, 2011. http://www.genmab.com/Science%20And%20Research/Products%20in%20Development/Zalutumumab.aspx.
  • 12
    • 79955392008 scopus 로고    scopus 로고
    • Panitumumab, Accessed January 31, 2011
    • Panitumumab, Accessed January 31, 2011. http://www.cancer.gov/search/resultsclinicaltrials.aspx?protocolsearchid=8073033.
  • 13
    • 33845689865 scopus 로고    scopus 로고
    • Facial hypertrichosis induced by cetuximab, an anti-EGFR monoclonal antibody
    • Kerob D., Dupuy A., Reygagne P., et al. Facial hypertrichosis induced by cetuximab, an anti-EGFR monoclonal antibody. Arch Dermatol 2006, 142:1656-1657.
    • (2006) Arch Dermatol , vol.142 , pp. 1656-1657
    • Kerob, D.1    Dupuy, A.2    Reygagne, P.3
  • 15
    • 49149087647 scopus 로고    scopus 로고
    • Promising newer molecular-targeted therapies in head and neck cancer
    • Wang L.X., Agulnik M. Promising newer molecular-targeted therapies in head and neck cancer. Drugs 2008, 68:1609-1619.
    • (2008) Drugs , vol.68 , pp. 1609-1619
    • Wang, L.X.1    Agulnik, M.2
  • 16
    • 61449104877 scopus 로고    scopus 로고
    • Targeted therapies in squamous cell carcinoma of the head and neck
    • Gold K.A., Lee H.-Y., Kim E.S. Targeted therapies in squamous cell carcinoma of the head and neck. Cancer 2009, 115:922-935.
    • (2009) Cancer , vol.115 , pp. 922-935
    • Gold, K.A.1    Lee, H.-Y.2    Kim, E.S.3
  • 17
    • 79955399681 scopus 로고    scopus 로고
    • Sorafenib tosylate, Accessed January 31, 2011
    • Sorafenib tosylate, Accessed January 31, 2011. http://www.cancer.gov/search/ResultsClinicalTrials.aspx?protocolsearchid=8115987.
  • 18
    • 78049460226 scopus 로고    scopus 로고
    • Does basal cell carcinoma belong to the spectrum of sorafenib-induced epithelial skin cancers?
    • Degen A., Satzger I., Voelker B., et al. Does basal cell carcinoma belong to the spectrum of sorafenib-induced epithelial skin cancers?. Dermatology 2010, 221:193-196.
    • (2010) Dermatology , vol.221 , pp. 193-196
    • Degen, A.1    Satzger, I.2    Voelker, B.3
  • 19
    • 73949143686 scopus 로고    scopus 로고
    • Phase II study of sunitinib in recurrent or metastatic squamous cell carcinoma of the head and neck: GORTEC 2006-01
    • Michaelis J.P., Henry S., Zanetta S., et al. Phase II study of sunitinib in recurrent or metastatic squamous cell carcinoma of the head and neck: GORTEC 2006-01. J Clin Oncol 2010, 28:21-28.
    • (2010) J Clin Oncol , vol.28 , pp. 21-28
    • Michaelis, J.P.1    Henry, S.2    Zanetta, S.3
  • 20
    • 74549125912 scopus 로고    scopus 로고
    • Basal cell nevus syndrome: A brave new world
    • Goldberg L.H., Firoz B.F., Weiss G.J., et al. Basal cell nevus syndrome: A brave new world. Arch Dermatol 2010, 146:17-19.
    • (2010) Arch Dermatol , vol.146 , pp. 17-19
    • Goldberg, L.H.1    Firoz, B.F.2    Weiss, G.J.3
  • 21
    • 72949103044 scopus 로고    scopus 로고
    • Small-molecule modulators of the Sonic Hedgehog signaling pathway
    • Stanton B.Z., Peng L.F. Small-molecule modulators of the Sonic Hedgehog signaling pathway. Mol Biosyst 2010, 6:44-54.
    • (2010) Mol Biosyst , vol.6 , pp. 44-54
    • Stanton, B.Z.1    Peng, L.F.2
  • 23
    • 70349238733 scopus 로고    scopus 로고
    • Inhibition of the hedgehog pathway in advanced basal-cell carcinoma
    • Von Hoff D.D., LoRusso P.M., Rudin C.M., et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009, 361:1164-1172.
    • (2009) N Engl J Med , vol.361 , pp. 1164-1172
    • Von Hoff, D.D.1    LoRusso, P.M.2    Rudin, C.M.3
  • 24
    • 70350496540 scopus 로고    scopus 로고
    • Smoothened mutation confers resistance to a hedgehog pathway inhibitor in medulloblastoma
    • Yauch R.L., Dijkgraaf G.J.P., Alicke B., et al. Smoothened mutation confers resistance to a hedgehog pathway inhibitor in medulloblastoma. Science 2009, 326:572-574.
    • (2009) Science , vol.326 , pp. 572-574
    • Yauch, R.L.1    Dijkgraaf, G.J.P.2    Alicke, B.3
  • 26
    • 77950647110 scopus 로고    scopus 로고
    • Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics
    • Peukert S., Miller-Moslin K. Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics. Chemmedchem 2010, 5:500-512.
    • (2010) Chemmedchem , vol.5 , pp. 500-512
    • Peukert, S.1    Miller-Moslin, K.2
  • 27
    • 34648832068 scopus 로고    scopus 로고
    • Dermatofibrosarcoma protuberans: Recent clinical progress
    • McArthur G.A. Dermatofibrosarcoma protuberans: Recent clinical progress. Ann Surg Oncol 2007, 14:2876-2886.
    • (2007) Ann Surg Oncol , vol.14 , pp. 2876-2886
    • McArthur, G.A.1
  • 28
    • 77950469922 scopus 로고    scopus 로고
    • Imatinib mesylate in advanced dermatofibrosarcoma protuberans: Pooled analysis of two phase II clinical trials
    • Rutkowski P., Von Glabbeke M., Rankin C.J., et al. Imatinib mesylate in advanced dermatofibrosarcoma protuberans: Pooled analysis of two phase II clinical trials. J Clin Oncol 2010, 28:1772-1779.
    • (2010) J Clin Oncol , vol.28 , pp. 1772-1779
    • Rutkowski, P.1    Von Glabbeke, M.2    Rankin, C.J.3
  • 29
    • 79751475654 scopus 로고    scopus 로고
    • Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection
    • Rutkowski P., Debiec-Rychter M., Nowecki Z., et al. Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection. J Eur Acad Dermatol Venereol 2011, 25:264-270.
    • (2011) J Eur Acad Dermatol Venereol , vol.25 , pp. 264-270
    • Rutkowski, P.1    Debiec-Rychter, M.2    Nowecki, Z.3
  • 30
    • 14144256775 scopus 로고    scopus 로고
    • Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225
    • McArthur G.A., Demetri G.D., van Oosterom A., et al. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. J Clin Oncol 2005, 23:866-873.
    • (2005) J Clin Oncol , vol.23 , pp. 866-873
    • McArthur, G.A.1    Demetri, G.D.2    van Oosterom, A.3
  • 31
    • 77953700949 scopus 로고    scopus 로고
    • Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: Results of a multicenter phase II study of 25 patients
    • Kerob D., Procher R., Verola O., et al. Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: Results of a multicenter phase II study of 25 patients. Clin Cancer Res 2010, 16:3288-3295.
    • (2010) Clin Cancer Res , vol.16 , pp. 3288-3295
    • Kerob, D.1    Procher, R.2    Verola, O.3
  • 32
    • 67650799353 scopus 로고    scopus 로고
    • Neoadjuvant imatinib therapy for dermatofibrosarcoma protuberans
    • Han A., Chen E.H., Niedt G., et al. Neoadjuvant imatinib therapy for dermatofibrosarcoma protuberans. Arch Dermatol 2009, 145:792-796.
    • (2009) Arch Dermatol , vol.145 , pp. 792-796
    • Han, A.1    Chen, E.H.2    Niedt, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.